|
1
|
Decimo I, Fumagalli G, Berton V, Krampera
M and Bifari F: Meninges: From protective membrane to stem cell
niche. Am J Stem Cells. 1:92–105. 2012.PubMed/NCBI
|
|
2
|
Etus V, Kurtkaya O, Koc K, Ciftci E, Sav A
and Ceylan S: Multisegmental spinal leptomeningeal fibrosis in
Riedel thyroiditis. Case illustration. J Neurosurg. 98(Suppl 3):
S2992003.
|
|
3
|
Robertson PL, Muraszko KM, Blaivas M and
Brunberg JA: Leptomeningeal fibrosis and the delayed diagnosis of a
central nervous system neoplasm (primitive neuroectodermal tumor).
Pediatr Neurol. 16:74–78. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhou G, Su X, Ma J, Wang L and Li D:
Pioglitazone inhibits high glucose-induced synthesis of
extracellular matrix by NF-κB and AP-1 pathways in rat peritoneal
mesothelial cells. Mol Med Rep. 7:1336–1342. 2013.PubMed/NCBI
|
|
5
|
Xiao L, Sun L, Liu FY, Peng YM and Duan
SB: Connective tissue growth factor knockdown attenuated matrix
protein production and vascular endothelial growth factor
expression induced by transforming growth factor-beta1 in cultured
human peritoneal mesothelial cells. Ther Apher Dial. 14:27–34.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Peng Y, Liu H, Liu F, Liu Y, Li J and Chen
X: Troglitazone inhibits synthesis of transforming growth
factor-beta1 and reduces matrix production in human peritoneal
mesothelial cells. Nephrology (Carlton). 11:516–523. 2006.
View Article : Google Scholar
|
|
7
|
Hung KY, Huang JW, Tsai TJ and Hsieh BS:
Peritoneal fibrosing syndrome: Pathogenetic mechanism and current
therapeutic strategies. J Chin Med Assoc. 68:401–405. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang Y, Zhang N, Lan F, Van Crombruggen K,
Fang L, Hu G, Hong S and Bachert C: Transforming growth factor-beta
1 pathways in inflammatory airway diseases. Allergy. 69:699–707.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Prud'homme GJ: Pathobiology of
transforming growth factor beta in cancer, fibrosis and immunologic
disease, and therapeutic considerations. Lab Invest. 87:1077–1091.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wei JL, Peng YM and Liu F: Connective
tissue growth factor and fibronectin secretion in renal tubular
epithelial cells induced by TGF-beta1: Suppressive effects of
troglitazone. Cell Biol Int. 31:30–34. 2007. View Article : Google Scholar
|
|
11
|
Li T, Zhang P, Yuan B, Zhao D, Chen Y and
Zhang X: Thrombin induced TGF-β1 pathway: A cause of communicating
hydrocephalus post subarachnoid hemorrhage. Int J Mol Med.
31:660–666. 2013.PubMed/NCBI
|
|
12
|
Zarubin T and Han J: Activation and
signaling of the p38MAP kinase pathway. Cell Res. 15:11–18. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wei LH, Han SG and Li T: Improvement on
culture in vitro of rat menigeal mesothelial cell. Chinese J
Neuroanat. 25:445–448. 2009.
|
|
14
|
Yang HJ, Wang L, Xia YY, Chang PN and Feng
ZW: NF-kappaB mediates MPP+-induced apoptotic cell death in
neuroblastoma cells SH-EP1 through JNK and c-Jun/AP-1. Neurochem
Int. 56:128–134. 2010. View Article : Google Scholar
|
|
15
|
Yang HJ, Xia YY, Wang L, Liu R, Goh KJ, Ju
PJ and Feng ZW: A novel role for neural cell adhesion molecule in
modulating insulin signaling and adipocyte differentiation of mouse
mesenchymal stem cells. J Cell Sci. 124:2552–2260. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Katz S, Balogh P, Nagy N and Kiss AL:
Epithelial-to-mesenchymal transition induced by Freund's adjuvant
treatment in rat mesothelial cells: A morphological and
immunocytochemical study. Pathol Oncol Res. 18:641–649. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rosellini A, Michelini M, Tanda G, Mandys
V and Revoltella RP: Expansion of human mesothelial progenitor
cells in a longterm three-dimensional organotypic culture of
Processus vaginalis peritonei. Folia Biol (Praha). 53:50–57.
2007.
|
|
18
|
Liu Q, Wang CY, Liu Z, Ma XS, He YH, Chen
SS and Bai XY: Hydroxysafflor yellow A suppresses liver fibrosis
induced by carbon tetrachloride with high-fat diet by regulating
PPAR-γ/p38 MAPK signaling. Pharm Biol. 52:1085–1093. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang L, Li Y, Chen M, Su X, Yi D, Lu P
and Zhu D: 15-LO/15-HETE mediated vascular adventitia fibrosis via
p38 MAPK-dependent TGF-β. J Cell Physiol. 229:245–257. 2014.
View Article : Google Scholar
|
|
20
|
Xu X, Xiao L, Xiao P, Yang S, Chen G, Liu
F, Kanwar YS and Sun L: A glimpse of matrix metalloproteinases in
diabetic nephropathy. Curr Med Chem. 21:3244–3260. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lan TH, Huang XQ and Tan HM: Vascular
fibrosis in atherosclerosis. Cardiovasc Pathol. 22:401–407. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lagèrze WA: New prospects in the treatment
of diabetic retinopathy: Current situation and pharmacological
developments. MMW Fortschr Med. 145:37–38. 2003.In German.
|
|
23
|
Tampe D and Zeisberg M: Potential
approaches to reverse or repair renal fibrosis. Nat Rev Nephrol.
10:226–237. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Leask A: Potential therapeutic targets for
cardiac fibrosis: TGFbeta, angiotensin, endothelin, CCN2, and PDGF,
partners in fibroblast activation. Circ Res. 106:1675–1680. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Crews L, Wyss-Coray T and Masliah E:
Insights into the pathogenesis of hydrocephalus from transgenic and
experimental animal models. Brain Pathol. 14:312–316. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xie S, Sukkar MB, Issa R, Khorasani NM and
Chung KF: Mechanisms of induction of airway smooth muscle
hyperplasia by transforming growth factor-beta. Am J Physiol Lung
Cell Mol Physiol. 293:L245–L253. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chang JZ, Yang WH, Deng YT, Chen HM and
Kuo MY: EGCG blocks TGFβ1-induced CCN2 by suppressing JNK and p38
in buccal fibroblasts. Clin Oral Invest. 17:455–461. 2013.
View Article : Google Scholar
|
